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ABSTRACT
Background: Hydatid disease is a worldwide health problem. Treatment is 
surgical or percutaneous, using scolicidal agents. Caustic sclerosing cholangitis might 
develop after the contact of scolicidal agents with the biliary ducts. Melatonin, an 
antioxidant, anti-inflammatory, and anticarcinogenic agent, might be used in the 
treatment of caustic sclerosing cholangitis due to its possible preventive effects on 
fibrosis and cell damage.
Objective: The aim of the study was to investigate the effects of melatonin on 
an experimentally developed caustic sclerosing cholangitis with scolicidal solution 
(formalin) in a rat model.
Methods: Forty female Sprague-Dawley rats aged 11 to 13 weeks and weighing 
250 ± 30 g were randomly assigned to 1 of 4 groups of 10: formalin 5% at 0.5 mL/d + 
melatonin placebo; formalin placebo + intraperitoneal melatonin 10 mg/kg/d; forma-
lin 5% at 0.5 mL/d + melatonin 10 mg/kg/d; and formalin placebo and melatonin 
placebo (control). Hepatobiliary function was assessed using dynamic scintigraphy 
with technetium-99m–mebrofenin on study day 60. The histology of the liver and 
biliary duct specimens was examined on study day 60. In each group, histopathologic 
alterations were scored as absent, slight, mild, or severe.
Results: Mean severity scores for parenchymal necrosis in the liver (P < 
0.01), portal fibrosis (P < 0.01), biliary duct proliferation (P < 0.001), cholangitis/
pericholangitis (P < 0.01), hyperemia in the biliary ducts (P < 0.01), and fibrosis 
(P < 0.01) were significantly lower in rats treated with formalin + melatonin com-
pared with those treated with formalin alone. No significant differences were observed 
between the 3 treatment groups with respect to t1/2, a parameter used to assess the 
secretion function of the hepatocytes. However, the t1/2 was significantly longer in the 
treatment groups compared with controls (P < 0.001).
Conclusion: In this experimental study in a rat model of caustic sclerosing cho-
langitis, the histopathologic and scintigraphic findings suggested that melatonin is effec-
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tive in attenuating the damage caused by scolicidal agents on the liver and biliary 
ducts. (Curr Ther Res Clin Exp. 2010;71:118–128) © 2010 Excerpta Medica Inc.
Key words: melatonin, hydatid cyst, scolicidal solutions, caustic sclerosing 
cholangitis.
INTRODUCTION
Hydatid disease, also known as echinococcosis,1 is a parasitic infestation characterized by 
cysts on the liver, lungs, and/or kidneys. Hydatid disease affects people living in or 
visiting endemic regions, especially Mediterranean, Middle Eastern, and African 
countries, as well as India and Australia.2 Hydatid disease is a public health issue with 
serious economic implications in affected countries.1 The most common site for a 
hydatid cyst is the liver, and in 5% to 10% of cases, the biliary ducts are also affected.3 
In cases in which the biliary ducts are affected, mortality and morbidity are increased, 
and treatment is affected.2
Treatment of hepatic hydatid cysts is surgical or percutaneous. During surgery, 
scolicidal agents (hypertonic saline 20%, povidone iodine 1%, silver nitrate 0.5%, or 
5% formalin) are injected into the cyst to deactivate the scolices. However, experi-
mental and clinical studies have reported that hepatic and biliary duct damage and 
caustic sclerosing cholangitis4–13 may result from contact between these agents and 
the liver and/or biliary duct during treatment.3 Sclerosing cholangitis is a chronic 
cholestatic disease characterized by inflammation, fibrosis, and stenosis of the intra-
hepatic and extrahepatic biliary ducts. During the natural progression of the disease, 
progressive biliary duct obstruction, biliary cirrhosis, hepatic failure, and cholangio-
carcinoma might be observed.14
Synthesized in the pineal gland from tryptophan, melatonin is an endogenous 
antioxidant agent, the effects of which are mediated through specific receptors 
found primarily in the brain and peripheral tissues. Melatonin has reported immune-
stimulating, anti-inflammatory, and anticarcinogenic effects; protective effects on 
cells, tissues, and organs against oxidative damage3,15–17; and preventive effects on 
fibrosis.3,15 As such, melatonin might be useful for attenuating caustic sclerosing 
cholangitis after surgical treatment of hepatic hydatid cysts.
In an experimental study, Montilla et al18 assessed the effects of melatonin and 
vitamin E on the cholestasis syndrome, and the preventive effects on hepatic damage, 
after extrahepatic biliary duct ligation in rats. A secondary objective was to investi-
gate the activity of antioxidant enzymes after treatment with these antioxidant drugs. 
They reported that melatonin was associated with a significantly hepatoprotective ef-
fect, including reductions in the negative parameters of cholestasis (serum bilirubin, 
P < 0.05; alkaline phosphatase, P < 0.01; and γ-glutamyl-transpeptidase, P < 0.001) 
and the degree of oxidative stress (malondialdehyde, P < 0.001; glutathione, P < 
0.001) compared with rats with extrahepatic biliary ligation. In a rat model of ob-
structive jaundice, Padillo et al19 found that melatonin was associated with protective 
effects against apoptosis and necrosis in hepatic damage. The authors investigated 
hepatic damage with the measurement of alanine aminotransferase and direct biliru-
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bin. Detection of apoptosis was assessed in fixed liver sections using immunohis-
tochemistry with double-stranded breaks that occurred during apoptosis. The sections 
were labeled with biotinylated nucleotides by terminal deoxynucleotidyl-transferase. 
The authors reported that the administration of melatonin was associated with signifi-
cant reductions in DNA fragmentation induced by cholestasis (P not reported) and 
that the obstruction of extrahepatic biliary duct was associated with significantly in-
creased concentrations of direct bilirubin (P < 0.001) and aminotransferase (P < 0.01). 
However, a literature search found no reports of the effects of melatonin on sclerosing 
cholangitis.
This study investigated the effects of melatonin, administered with a scolicidal 
solution (formalin), on the attenuation of damage of the liver and biliary ducts in a rat 
model of caustic sclerosing cholangitis. 
MATERIALS AND METHODS
Study Design
The study was conducted at the Laboratory Animals Care Unit in accordance with 
the guidelines for the care and use of laboratory animals established by the Animal 
Ethics Committee, which approved the study design. Forty female Sprague-Dawley 
rats aged 11 to 13 weeks and weighing 250 ± 30 g were studied. Using a computer-
generated table of random numbers, rats were assigned to 1 of 4 groups of 10: for- 
malin (lot no. F-22432, Eczacibasi Ilac Sanayi, Levent, Istanbul, Turkey) 5% at 
0.5 mL/d + melatonin placebo (formalin group); intraperitoneal melatonin (lot no. 
M-5250, Sigma Chemical Co., Steinheim, Germany) 10 mg/kg/d + formalin placebo 
(melatonin group); formalin 5% at 0.5 mL/d + melatonin 10 mg/kg/d (formalin + 
melatonin group); and formalin placebo + melatonin placebo (control group).
The animal room was maintained at a temperature of 22°C ± 2°C and a relative 
humidity of 55% ± 15%, with a 12-hour light–dark cycle. Tap water was freely avail-
able throughout the acclimatization and study periods. The schedule of the experi-
ment was constructed as formalin administration on study day 1, melatonin adminis-
tration on days 1 to 14, and hepatobiliary scintigraphy and euthanasia on day 60. 
Formalin Administration 
Each rat was anesthetized using 5 mg/kg of xylazine and 30 mg/kg of ketamine 
hydrochloride intramuscularly before surgery. After laparotomy, biliary ducts of 
the rats administered formalin or formalin + melatonin were cannulized using a 
33-G catheter, and 0.5 mL of 5% formalin was administered. The biliary duct was 
clamped at the distal end for ~5 minutes. The same procedure was used in the mela-
tonin and control groups, and 0.5 mL of 0.09% NaCl was administered through the 
biliary duct.
Melatonin Administration 
Rats in the melatonin and formalin + melatonin groups were administered 10 mg/kg/d 
of melatonin intraperitoneally for 14 days, starting on study day 1. The formalin and 
control groups received the same amount of 0.09% NaCl intraperitoneally for 14 days.
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Hepatobiliary Scintigraphy
On day 60, before euthanasia, hepatobiliary activity was detected in all 4 animal 
groups using a 37-MBq injection of technetium-99m (99mTc)–mebrofenin (Bridatech, 
Amersham International, London, United Kingdom), a bilirubin analogue pharma- 
ceutically used in hepatic scintigraphy, via the tail vein. The scintigrams were examined 
by a blinded nuclear medicine specialist. Dynamic scintigraphy, a noninvasive and 
repeatable method used to assess the liver and biliary ducts, was conducted for 60 min-
utes (1 frame/min). Following intravenous injection of mebrofenin, almost all of the 
mebrofenin is taken up rapidly by hepatocytes and secreted into the biliary ducts.
On the dynamic images, circular regions of interest (ROIs) were drawn on the up-
per right quadrant of the liver to exclude the activities of the major biliary tract, gut, and 
right kidney. From these ROIs, time–activity curves were generated for each group, 
and time of peak uptake (TPU) and t1/2 were calculated.
TPU is used to assess the extraction function of the hepatocytes, and 99mTc-mebrofenin 
denotes the time from injection to highest concentration of mebrofenin in the liver. 
A higher 99mTc-mebrofenin value is a quantitative indicator of impaired hepatocyte 
extraction function. The t1/2 value was used for the assessment of the secretion func-
tion of the hepatocytes because it indicates the rate of extraction of 99mTc-mebrofenin, 
concentrated by hepatocytes after extraction, into the biliary duct. The t1/2 of peak 
activity was used for the measurement of the secretion rate, and a delay in this time 
suggests impaired secretory function of the hepatocytes.
Histopathologic Assessment of Liver and Biliary Duct 
On day 60, rats were euthanized using cardiac exsanguination under a surgical 
plane of ketamine and xylazine anesthesia. The liver and biliary duct specimens were 
excised for histopathologic assessment. Representative sections of all liver and biliary 
duct segments were embedded in paraffin after fixation of the tissues in 10% neutral 
buffered formalin. Five-micrometer sections were obtained from each paraffin block 
and stained with hematoxylin and eosin. Slides were examined in duplicate by 
a blinded pathologist under a light microscope (Nikon Eclipse E600, Nikon, Mel-
ville, New York). In hepatic tissue, hepatic parenchyma necrosis, hyperemia, portal 
inflammation, portal fibrosis, proliferation of biliary canaliculi, and cholangitis/ 
pericholangitis, and in biliary duct tissues hyperemia and fibrosis were assessed un-
der the light microscope. In each group, histopathologic alterations were scored as 
absent (0), slight (1), mild (2), and severe (3).16
Statistical Analysis 
The numeric results were expressed as mean (SD). Severity scores were expressed as 
median (range) due to non-normal distribution. Normality of distribution of the vari-
ables was tested using the 1-sample Kolmogorov-Smirnov test. The Kruskal-Wallis 
test was used to compare differences between groups due to abnormal distribution, 
and the Mann-Whitney U test with Bonferroni correction was used if a significance 
result was obtained. A P value <0.05 was considered statistically significant. Statistica 
7.0 (StatSoft Inc., Tulsa, Oklahoma) was used for statistical analyses.
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RESULTS
In the 40 rats studied, no deaths occurred in the melatonin or control groups. 
Two rats died within 2 hours in the formalin group, and 1 rat died in the formalin + 
melatonin group after the drug administration. On necropsy, the main causes of death 
were considered iatrogenic portal vein catheterization and formalin injection through 
the catheter. 
Histopathologic Examination
Statistical values from the histopathologic examinations of the groups are shown in 
Table I. No significant histopathologic alterations were found in the melatonin or 
control group, with the exception of slight hyperemia in the control group (1 rat). On 
examination of the livers and biliary ducts in the formalin group, severe damage was 
found in 5 rats. Parenchymal necrosis in the liver, portal inflammation, portal fibro- 
sis, biliary duct proliferation, and mild hyperemia were found in the formalin + 
melatonin group. Mild and slight hyperemia, cholangitis/pericholangitis, and fibrosis 
were noted in biliary duct sections in the formalin + melatonin group (Figure 1). 
Mean severity scores of parenchymal necrosis in the liver (P < 0.01), portal fibrosis 
(P < 0.01), biliary duct proliferation (P < 0.001), cholangitis/pericholangitis (P < 
0.01), hyperemia in the biliary ducts (P < 0.01), and fibrosis (P < 0.01) were signifi-
cantly lower in the formalin + melatonin group compared with the formalin group.
Table I.  Histopathologic scores in this study of the effects of melatonin on caustic scle-
rosing cholangitis with scolicidal solution (formalin) in a rat model. Values are 
median (range).
   Formalin + 
 Formalin Melatonin Melatonin Control 
Specimen (n = 10) (n = 10) (n = 10) (n = 10) P a
Hepatic parenchyma 
  necrosis 1 (0–2)b,c 0 (0–0) 0 (0–0)d 0 (0–0) <0.001
Hyperemia in liver 2 (1–3)c,e 1 (0–1) 1 (1–3)f,g 1 (1–1) <0.001
Portal inflammation 1 (0–3)b,c 0 (0–0) 1 (0–1)b,h 0 (0–0) <0.001
Portal fibrosis 1 (0–2)b,c 0 (0–0) 0 (0–1)d 0 (0–0) <0.001
Proliferation of  
  bile canaliculi 2 (1–3)c,e 0 (0–1) 0.5 (0–1)f,i 0 (0–0) <0.001
Cholangitis/pericholangitis 2 (1–2)c,e 0 (0–1) 1 (0–1)b,d,h 0 (0–1) <0.001
Hyperemia in biliary duct 2 (1–2)c,e 0 (0–1) 1 (1–1)c–e 0 (0–1) <0.001
Fibrosis in biliary duct 2 (1–3)c,e 0 (0–1) 1 (0–2)d,f,h 0 (0–1) <0.001 
a Kruskal-Wallis test.  f P < 0.05 versus control.
b P < 0.01 versus control.  g P < 0.05 versus melatonin.
c P < 0.001 versus melatonin.  h P < 0.01 versus melatonin.
d P < 0.01 versus formalin.  i P < 0.001 versus formalin.
e P < 0.001 versus control.
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Figure 1.  Histologic effects of melatonin on caustic sclerosing cholangitis with scolicidal 
solution (formalin) in a rat model. (A) Formalin group: (1) liver showing prominent 
ductular reaction and prominent reactive nuclear atypia in the hepatic cells (mag-
nification, ×100); (2) biliary duct showing prominent inflammatory infiltration 
in and around biliary duct mucosa, and intraluminal leucocyte infiltration (×50). 
(B) Melatonin group: (1) liver showing minimal histology (×50); (2) biliary duct 
showing minimal chronic inflammation (×100). (C) Formalin + melatonin group: 
(1) liver showing minimal sinusoidal dilatation and minimal congestion of the 
portal vein (×50); (2) biliary duct showing minimal chronic inflammation (×50). 
(D) Control group: (1) liver showing normal histology (× 50); (2) biliary duct with 
normal histology (×50). (All staining, hematoxylin and eosin.)
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Hepatobiliary Scintigraphic Examination
Mean TPU and t1/2 values in all 4 groups and the statistical analyses of the groups 
are shown in Table II and Figure 2. The TPUs in the control group did not differ 
significantly between the melatonin, formalin + melatonin, and control groups. 
A significant delay in TPU was found in the formalin group compared with controls 
(P = 0.001). No significant differences were observed between the formalin, mela-
tonin, and formalin + melatonin groups with respect to t1/2 values. The t1/2 values 
were significantly longer in those groups than in the control group (P < 0.001).
Table II.  Scintigraphic parameters in this study of the effects of melatonin on caustic 
sclerosing cholangitis with scolicidal solution (formalin) in a rat model. Values 
are mean (SE).
   Formalin + 
 Formalin Melatonin Melatonin Control 
Parameter (n = 10) (n = 10) (n = 10) (n = 10) P*
TPU, min (extraction) 17.2 (6.1)† 9.1 (2.7) 5.6 (0.5)‡ 3.2 (0.1) 0.001
t1/2, min (secretion) 48.3 (6.1)
† 13.4 (7.4)† 44.1 (7.8)† 6.9 (0.2) 0.001 
TPU = time of peak uptake.
*Kruskal-Wallis test.
† P < 0.001 versus control.
‡ P < 0.001 versus formalin.
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Figure 2.  The time–activity curve of technetium-99m (99mTc)–mebrofenin in this study of 
the effects of melatonin on caustic sclerosing cholangitis with scolicidal solu-
tion (formalin) in a rat model. TPU = time of peak uptake (extraction).
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DISCUSSION
This study used formalin, a scolicidal agent associated with caustic sclerosing cholan-
gitis in a number of clinical and experimental studies.8,10,12 When the data from the 
formalin group were compared to those from the controls, hyperemia in hepatic tissue, 
portal inflammation, portal fibrosis, proliferation in biliary ducts, and cholangitis, 
hyperemia, and fibrosis progression were detected at advanced stages in the biliary 
duct. In accordance with the literature, these data support the hypothesis that forma-
lin might lead to caustic sclerosing cholangitis. The onset of scolicidal-induced scle-
rosing cholangitis was between 1 week and 1 year in humans.12 Although different 
scolicidal agents are used in experimental models of caustic sclerosing cholangitis and 
histopathologic assessment is carried out at different time intervals, histopathology 
suggested caustic sclerosing cholangitis on study day 60. Critical histopathologic and 
scintigraphic results were also found, suggesting that contact between scolicidal 
agents (eg, formalin) and the intra- and extrabiliary ducts might lead to caustic scle-
rosing cholangitis. 
The group administered formalin + melatonin was observed to have significantly 
less damage in terms of parenchymal necrosis in the liver (P < 0.01), portal fibrosis 
(P < 0.01), biliary duct proliferation (P < 0.001), cholangitis/pericholangitis (P < 
0.01), hyperemia in the biliary ducts (P < 0.01), and fibrosis (P < 0.01) compared 
with the formalin group. Esrefoglu et al16 reported a significantly protective effect of 
melatonin against fibrosis (P < 0.05), necrosis (P < 0.05), and portal inflammation 
(P < 0.05) of the liver in an experimental model of obstructive jaundice. In a study by 
Cruz et al,20 the effects of melatonin were investigated in an experimental model of 
liver cirrhosis induced by thioacetamide. Liver injury was assessed using serologic 
analysis, as well as hematoxylin-eosin staining and the in situ apoptosis detection 
assay in liver sections. Oxidative stress was assessed using lipoperoxide and reduced 
glutathione levels, and by the measurement of catalase and superoxide dismutase 
activities in liver and serum. The study reported significantly less liver damage with 
thioacetamide with melatonin administration than without melatonin (lipoperoxide 
(P < 0.01), glutathione (P < 0.01), catalase (P ≤ 0.01), and superoxide dismutase 
(P ≤ 0.01). Padillo et al19 reported that melatonin was associated with significantly 
less oxidative stress and hepatocyte destruction compared with controls in an experi-
mental model of obstructive jaundice. In accordance with the literature,16,17,19 data 
from the present study suggest that melatonin might attenuate the development of 
caustic sclerosing cholangitis resulting from scolicidal agent administration in the 
biliary ducts and liver.
The development of fibrosis is crucial in the progression of sclerosing cholangitis, 
and treatment protocols to impede this stage have been designed. Carossino et al21 
investigated the effects of melatonin in an experimental model of scleroderma. The 
authors assessed the growth rate based on growth curves and a 3H-thymidine incor-
poration assay. They reported that a dose of 200 μg/mL of melatonin attenuates 
(>80%) systemic sclerosis fibroblast activity. Those findings suggest that melatonin 
may attenuate the proliferation of fibroblasts derived from the skin of healthy subjects 
and patients with systemic sclerosis. A study of the attenuation of fibrosis formation 
¸ ˘
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in rats was conducted by Hatipoglu et al,22 who reported favorable effects of mela-
tonin on decreasing postoperative intra-abdominal adhesion formation. In an experi-
mental design, 3 groups were studied—sham laparotomy, ischemia reperfusion, and 
ischemia reperfusion + melatonin. They assessed the effects of melatonin on intra-
abdominal adhesion formation by blood glutathione peroxidase and microscopic and 
macroscopic adhesion scores. The authors reported that the glutathione peroxidase 
concentrations were significantly higher (P = 0.026) and fibroblast proliferation and 
macroscopic adhesion scores were significantly lower (P = 0.001), in the melatonin-
treated group than in the melatonin-free group. They suggested that melatonin ad-
ministration has beneficial effects on postoperative intra-abdominal adhesions. Con-
sistent with the literature,21,22 the present study found that the extent of fibrosis in 
the liver and biliary duct was significantly less in the formalin + melatonin group 
than in the formalin group (P < 0.01). Sahna et al23 reported an elevation in conges-
tive dilatation and mononuclear cell infiltration in the hepatic sinusoids of pinealec-
tomized rats (ie, those with no endogenous melatonin). The authors investigated the 
effects of pinealectomy and administration of exogenous melatonin on liver tissue in 
rats. The structural changes and glutathione and malondialdehyde concentrations 
were assessed in the experimental design. Liver glutathione levels were significantly 
lower in pinealectomized rats than in the control group. Melatonin administration 
was associated with significantly increased glutathione concentrations (P < 0.05). 
Pinealectomy was associated with a significant increase in malondialdehyde concen-
trations compared with the control group (P < 0.05), and melatonin administration 
in pinealectomized rats was associated with significantly reduced malondialdehyde 
concentrations in the liver (P < 0.05). The authors suggested that a significant in-
crease in oxidative and structural changes occur in rat livers after pinealectomy, 
and that these changes might be diminished by melatonin treatment. Messner et al24 
reported that the melatonin concentration in portal venous blood was higher com-
pared with that in peripheral venous blood samples (by 20%–30%). A protective ef-
fect of melatonin, through the attenuation of oxidative stress and inflammation in 
thioacetamide-induced hepatic damage, was established in another experimental rat 
study.25 The author reported that serum liver enzymes and blood ammonia were lower 
in rats treated with thioacetamide + melatonin compared with thioacetamide mono-
therapy (P < 0.001). Liver histology was significantly improved and the mortality in the 
melatonin-treated rats was significantly decreased (P < 0.001). Aust et al26 assessed 
melatonin receptors located in human gallbladder epithelia and proposed that mela-
tonin might have a protective effect on the biliary duct. On histopathology, formalin-
induced biliary duct and hepatic damage might have been reduced with melatonin 
use. It appears that melatonin mediates this effect by eliminating oxidants released as 
a result of destruction developing with scolicidal agents in biliary duct epithelia by 
having an anti-inflammatory effect on released mediators or by attenuating fibrosis, 
which is crucial in the development of sclerosing cholangitis.25 Further studies, sup-
ported by laboratory data, are necessary to elucidate this issue.
A review of the literature found in the MEDLINE, EMBASE, and Ovid databases, 
published from 1965 through 2009, found no studies on the topics including the 
˘
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effect of melatonin on caustic sclerosing cholangitis due to scolicidal agents or assess-
ments of the results on histopathology and scintigraphy. Because the literature search 
found no studies of the effects of scolicidal agents on the liver or biliary duct, or stud-
ies of prevention methods, no scintigraphic data were available. On scintigraphy in 
this study, no significant differences were observed between the melatonin, formalin + 
melatonin, and control groups with respect to TPU, whereas there were significant 
differences between the formalin group and the other groups. On scintigraphy, mela-
tonin apparently provided protection for the extraction function of the hepatocytes in 
the liver against the damage caused by scolicidal agents. These findings were sup-
ported on histopathology. Although no significant differences were found between the 
formalin, melatonin, and formalin + melatonin groups on scintigraphy, there were 
significant differences between these groups and controls. This study did not find 
significant results that suggested that melatonin provides protection for the biliary 
secretory function against the damage caused by scolicidal agents. However, statisti-
cally significant differences versus controls suggested attenuating effects of melatonin 
on the extraction function of the hepatocytes.
Further experimental and clinical studies in humans, using scolicidal agents that 
do not cause as much tissue damage as does formalin, are needed to confirm the find-
ings from this study of the effects of melatonin.
CONCLUSION
In this experimental study in a rat model of caustic sclerosing cholangitis, the histo-
pathologic and scintigraphic findings suggested that melatonin is effective in attenu-
ating the damage caused by scolicidal agents in the liver and biliary ducts.
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